Clinical Trial Update: Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining correlation between efficacy of osimertinib and EGFR T790M status using ddPCR in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Osimertinib (osimertinib)

Snippet

Sponsor: Peking Union Medical College | Conditions: EGFR T790M, Osimertinib | Phase 2 | Status: UNKNOWN